Quipt Home Medical Corp. (QIPT)

Quipt Home Medical Corp. provides in-home medical equipment and supplies, focusing on chronic disease management. The company offers a range of respiratory and durable medical equipment in the United States.

45/100 AI Score MCap 154M Vol 2M

Company Overview

CEOGregory John Crawford
Employees1200
HeadquartersWilder, KY, US
IPO Year2010

Quipt Home Medical delivers in-home respiratory and durable medical equipment, targeting the expanding chronic disease management market with a focus on superior patient care and efficient service delivery, positioning them for sustained growth in a fragmented industry.

Investment Thesis

Quipt Home Medical presents a compelling investment opportunity due to its strategic focus on the expanding home healthcare market and chronic disease management. The company's comprehensive product and service offerings, coupled with its established presence in the United States, position it for sustained growth. Key value drivers include increasing demand for in-home respiratory care, an aging population, and the growing prevalence of chronic diseases. A potential catalyst is the company's ability to execute strategic acquisitions to expand its geographic footprint and service capabilities. With a current market capitalization of $0.16 billion, Quipt offers significant upside potential as it continues to scale its operations and improve profitability. While the company currently has a negative P/E ratio of -14.39 and a negative profit margin of -3.9%, the gross margin of 65.3% indicates a strong potential for future profitability as the company achieves greater economies of scale.

Key Highlights

  • Gross margin of 65.3% demonstrates strong pricing power and efficient cost management in the provision of medical equipment and services.
  • Focus on chronic disease management aligns with the growing prevalence of conditions like COPD and sleep apnea, creating a sustainable demand for Quipt's products and services.
  • Strategic acquisitions have expanded Quipt's geographic footprint and service offerings, driving revenue growth and market share gains.
  • The company's beta of 0.56 suggests lower volatility compared to the overall market, potentially making it a more stable investment.
  • Quipt's comprehensive range of respiratory and durable medical equipment positions it as a one-stop shop for patients and healthcare providers, enhancing customer loyalty and retention.

Competitors

Strengths

  • Comprehensive range of in-home medical equipment and supplies.
  • Focus on chronic disease management.
  • Established relationships with healthcare providers.
  • Scalable business model.

Weaknesses

  • Negative profit margin.
  • High reliance on reimbursement rates from payers.
  • Competition from larger players in the industry.
  • Limited geographic presence compared to larger competitors.

Catalysts

  • Upcoming: Potential acquisitions to expand geographic footprint and service capabilities.
  • Ongoing: Increasing demand for in-home respiratory care due to aging population and chronic disease prevalence.
  • Ongoing: Expansion of telehealth and remote patient monitoring services.
  • Ongoing: Development and implementation of value-based care programs.

Risks

  • Potential: Changes in government regulations and reimbursement policies could negatively impact revenue.
  • Potential: Increased competition from larger, more established players in the home medical equipment market.
  • Potential: Product liability claims or recalls could damage the company's reputation and financial performance.
  • Ongoing: Economic downturn could reduce patient spending on elective medical equipment and supplies.

Growth Opportunities

  • Expansion into New Geographic Markets: Quipt has the opportunity to expand its presence into new geographic markets through strategic acquisitions and organic growth. By targeting underserved areas with a high prevalence of chronic diseases, Quipt can increase its customer base and revenue streams. The market for home medical equipment is estimated to reach $36 billion by 2028, providing ample opportunity for growth. Timeline: Ongoing.
  • Increased Focus on Telehealth and Remote Patient Monitoring: Quipt can leverage telehealth and remote patient monitoring technologies to enhance patient care and improve operational efficiency. By offering remote consultations and monitoring services, Quipt can expand its reach and provide more convenient access to care. The telehealth market is projected to reach $55 billion by 2027. Timeline: Ongoing.
  • Development of Value-Based Care Programs: Quipt can partner with healthcare providers and payers to develop value-based care programs that focus on improving patient outcomes and reducing healthcare costs. By demonstrating the value of its services, Quipt can attract new customers and increase its market share. Timeline: Ongoing.
  • Strategic Acquisitions of Smaller Competitors: The fragmented nature of the home medical equipment market presents opportunities for Quipt to acquire smaller competitors and consolidate its market position. By acquiring companies with complementary product lines or geographic footprints, Quipt can expand its offerings and reach. Timeline: Ongoing.
  • Expansion of Product and Service Offerings: Quipt can expand its product and service offerings to include new technologies and therapies. By staying at the forefront of innovation, Quipt can attract new customers and differentiate itself from competitors. This includes exploring new respiratory therapies and advanced monitoring devices. Timeline: Ongoing.

Opportunities

  • Expansion into new geographic markets.
  • Increased adoption of telehealth and remote patient monitoring.
  • Development of value-based care programs.
  • Strategic acquisitions of smaller competitors.

Threats

  • Changes in reimbursement policies.
  • Increased competition from other home medical equipment providers.
  • Economic downturn affecting patient spending.
  • Product recalls or safety concerns.

Competitive Advantages

  • Established relationships with healthcare providers and payers.
  • Comprehensive product and service offerings.
  • Expertise in managing chronic disease states.
  • Scalable business model with potential for geographic expansion.

About

Quipt Home Medical Corp., formerly known as Protech Home Medical Corp., was incorporated in 1993 and is headquartered in Wilder, Kentucky. The company changed its name in May 2021, reflecting its evolution and strategic focus. Quipt provides a comprehensive suite of in-home medical equipment and supplies, with a strong emphasis on respiratory and durable medical equipment (DME). Their core business revolves around managing chronic disease states, particularly for patients suffering from heart and pulmonary diseases, sleep disorders, reduced mobility, and other chronic health conditions. Quipt offers a wide array of products, including nebulizers, oxygen concentrators, CPAP and BiPAP units, ventilator equipment, mobility aids, and power wheelchairs. They also provide oxygen therapy, bariatric equipment, bathroom safety products, and equipment for treating sleep apnea and chronic obstructive pulmonary disease (COPD). In addition to equipment sales, Quipt generates revenue through respiratory equipment rentals and related services, solidifying its position as a key player in the home medical equipment market. Quipt's geographic reach is across the United States, serving a diverse patient base with varying needs.

What They Do

  • Provides in-home medical equipment and supplies.
  • Offers respiratory and durable medical equipment.
  • Manages chronic disease states for patients with heart and pulmonary disease.
  • Provides equipment for patients with sleep disorders.
  • Offers solutions for patients with reduced mobility.
  • Rents respiratory equipment such as oxygen concentrators and CPAP/BiPAP units.
  • Sells and services ventilators and related equipment.

Business Model

  • Sales of durable medical equipment and supplies.
  • Rental of respiratory equipment.
  • Service and maintenance of medical equipment.
  • Management of chronic disease states through equipment and support.

Industry Context

Quipt Home Medical operates within the growing home healthcare market, driven by an aging population and the increasing prevalence of chronic diseases. The industry is characterized by a shift towards value-based care and a preference for in-home treatment options. The market is fragmented, with numerous regional and national players. Quipt competes with companies like AdaptHealth (ANEB), Apria Healthcare (APYX), and other providers of durable medical equipment and respiratory services. The industry is expected to continue growing, fueled by technological advancements and increasing healthcare expenditures.

Key Customers

  • Patients with chronic respiratory conditions (COPD, asthma).
  • Patients with sleep disorders (sleep apnea).
  • Patients with mobility issues requiring wheelchairs or walkers.
  • Hospitals and healthcare providers needing equipment for home-based care.
AI Confidence: 72% Updated: 2/8/2026

Financials

Recent Quarterly Results

Quarter Revenue Net Income EPS
Q4 2025 $110M -$1M $0.00
Q3 2025 $94M -$5M $0.00
Q2 2025 $80M -$4M $0.00
Q1 2025 $80M -$4M $0.00

Source: Company filings

Chart & Info

Price Chart

Quipt Home Medical Corp. (QIPT) stock price: $3.55 (+0.02, +0.57%)

Why Bull

  • •Quipt's recent insider buying suggests management believes the stock is undervalued, signaling confidence in future performance. Think of it like when Elon Musk bought Tesla shares, reinforcing investor faith.
  • •Community sentiment indicates growing optimism about Quipt's expansion into new markets, which could drive revenue growth. It's similar to how early adopters fueled Netflix's initial subscriber growth.
  • •Bullish views highlight the company's strong position in the home medical equipment sector, a market expected to expand with an aging population. This is akin to the demand surge for telehealth services during the pandemic.
  • •Recent market perception suggests Quipt is successfully integrating acquisitions, streamlining operations and reducing costs. This is reminiscent of how successful mergers in the airline industry created economies of scale.

Why Bear

  • •Recent insider selling, even if for personal reasons, can create negative market perception and raise concerns about the company's prospects. It's comparable to when key executives sold Lehman Brothers stock before the 2008 crash.
  • •Bearish community views express concerns about increased competition in the home medical equipment market, potentially impacting Quipt's market share. It mirrors the challenges faced by Blockbuster as Netflix gained dominance.
  • •Market perception suggests that regulatory changes in healthcare could negatively affect Quipt's reimbursement rates, impacting profitability. This is similar to how pharmaceutical companies react to potential drug price controls.
  • •Community sentiment indicates worries about Quipt's debt levels, especially in a rising interest rate environment, which could strain the company's financial resources. Think of it like the debt crisis faced by many retailers as online shopping surged.

Latest News

Technical Analysis

RSI(14)
--
MACD
--
Volume
1,451,694

Rationale

AI-generated technical analysis for QIPT including trend direction, momentum, and pattern recognition.

What to Watch

Key support and resistance levels, volume signals, and upcoming events.

Risk Management

Position sizing, stop-loss levels, and risk-reward assessment.

Community

Discussion

Share your analysis and discuss Quipt Home Medical Corp. (QIPT) with other investors. Log in to post.

Sentiment

Community sentiment and discussion activity for QIPT.

Make a Prediction

Set your price target for Quipt Home Medical Corp. (QIPT), choose a timeframe, and track your prediction accuracy.

Current price: $3.55

Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for QIPT.

Price Targets

Wall Street price target analysis for QIPT.

Insider Flow (30d)

Crawford Gregory John
Insider
2 months ago
BOUGHT
3,373,696 shares
$3.7M

MoonshotScore

44.5/100

Score Factors

  • Revenue Growth 2/100

    Revenue declined -3.4% YoY, signaling shrinking demand or market headwinds.

  • Gross Margin 10/100

    Gross margin of 72.4% shows excellent pricing power and a strong competitive moat.

  • Operating Leverage 4/100

    Limited operating leverage due to slower revenue growth, keeping profit scaling constrained.

  • Cash Runway 5/100

    Cash position data is currently unavailable for this company.

  • R&D Intensity 5/100

    R&D spending data is currently unavailable for this company.

  • Insider Activity 6/100

    No significant insider buying or selling recently, which is neutral for the stock outlook.

  • Short Interest 5/100

    Float and volume data unavailable for liquidity analysis.

  • Price Momentum 0/100

    No bullish technical signals detected. The stock lacks upward price momentum currently.

  • News Sentiment 5/100

    No sentiment data available

What does this score mean?

The MoonshotScore rates QIPT's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

Frequently Asked Questions

What does Quipt Home Medical Corp. do?

Quipt Home Medical Corp. is a provider of in-home medical equipment and supplies, with a focus on respiratory and durable medical equipment. They cater to patients managing chronic diseases such as COPD, sleep apnea, and heart conditions. Quipt's business model involves selling and renting medical equipment, providing related services, and managing chronic disease states through equipment and support. The company operates primarily in the United States, serving a diverse patient base and partnering with healthcare providers to deliver comprehensive home-based care solutions.

Is QIPT stock a good buy?

QIPT stock presents a mixed investment profile. While the company's focus on the growing home healthcare market and chronic disease management is promising, its current negative P/E ratio of -14.39 and negative profit margin of -3.9% raise concerns. However, the strong gross margin of 65.3% suggests potential for improved profitability as the company scales. Investors should consider the company's growth catalysts, such as strategic acquisitions and expansion into new markets, alongside the risks associated with reimbursement policies and competition. A balanced approach is recommended, considering both the potential upside and the inherent risks.

What are the main risks for QIPT?

The main risks for Quipt Home Medical include potential changes in government regulations and reimbursement policies, which could significantly impact revenue. Increased competition from larger, more established players in the home medical equipment market poses a threat to market share. Product liability claims or recalls could damage the company's reputation and financial performance. An economic downturn could reduce patient spending on elective medical equipment and supplies, affecting sales and profitability. These factors should be carefully considered by investors.

Is QIPT a good stock to buy?

Whether QIPT is a good investment depends on your financial goals, risk tolerance, and investment horizon. Key factors to evaluate include the company's revenue growth trajectory, profit margins, debt-to-equity ratio, competitive moat, and valuation multiples (P/E, P/S, EV/EBITDA) relative to industry peers. Our AI-generated Investment Thesis and SWOT analysis on this page provide a data-driven starting point. Always do your own research and consider consulting a financial advisor before making investment decisions.

What is the QIPT MoonshotScore?

The MoonshotScore for QIPT is an AI-powered rating from 0 to 100 that evaluates a stock across four dimensions: growth potential (revenue and earnings trajectory), financial health (balance sheet strength, cash flow), market momentum (price trends, volume patterns, institutional flows), and risk factors (volatility, debt levels, sector headwinds). Scores above 70 indicate strong potential, 50-70 moderate, and below 50 suggests caution. The score is recalculated daily using the latest financial data and market signals.

How often is QIPT data updated?

QIPT stock prices are updated in real-time during U.S. market hours (9:30 AM - 4:00 PM ET, Monday through Friday). After-hours and pre-market prices are also tracked. Company fundamentals (earnings, revenue, balance sheet) are refreshed when new quarterly or annual reports are filed. Analyst ratings, price targets, and AI-generated insights are updated daily. Breaking news related to QIPT is aggregated continuously from premium financial news sources throughout the day.

What are the growth catalysts for QIPT?

Growth catalysts for Quipt Home Medical Corp. (QIPT) can include several categories: product catalysts (new launches, FDA approvals, patent grants), financial catalysts (earnings beats, margin expansion, share buybacks), strategic catalysts (acquisitions, partnerships, market expansion into new regions), and macro catalysts (favorable regulation, industry tailwinds, secular growth trends). Our AI analyzes Quipt Home Medical Corp.'s specific catalysts using earnings transcripts, SEC filings, and news sentiment to identify the most impactful near-term and long-term drivers.

Who are QIPT's main competitors?

Quipt Home Medical Corp. (QIPT) competes with companies in its industry that target similar customers, markets, or product categories. Competitor analysis involves comparing key metrics: market share, revenue growth rates, profit margins, R&D spending, and valuation multiples. Understanding competitive positioning helps investors assess whether QIPT has a sustainable competitive advantage (moat) through brand strength, network effects, cost leadership, or switching costs. Our Competitors section provides a side-by-side comparison with relevant peers.

What do analysts say about QIPT?

Wall Street analyst coverage for QIPT includes consensus ratings (buy, hold, or sell), 12-month price targets, and earnings estimates. Analyst opinions are aggregated from major investment banks and research firms. Key metrics to watch include the consensus price target (average, high, and low estimates), the number of analysts covering the stock, any recent rating changes (upgrades or downgrades), and how actual earnings compare to analyst estimates (beat or miss history). Our platform aggregates these from multiple data providers for a comprehensive view.

What is QIPT's market cap?

Market capitalization (market cap) for QIPT is calculated by multiplying the current share price by the total number of outstanding shares. It represents the market's total valuation of the company. Stocks are typically categorized as mega-cap ($200B+), large-cap ($10B-$200B), mid-cap ($2B-$10B), small-cap ($300M-$2B), or micro-cap (under $300M). Market cap influences index inclusion, institutional ownership eligibility, and risk profile. Our Key Statistics section shows QIPT's current market cap alongside enterprise value and other valuation metrics.

How has QIPT stock performed recently?

QIPT's recent stock performance can be evaluated across multiple timeframes: daily price changes, week-over-week momentum, monthly trends, and year-to-date returns. Important performance indicators include the stock's 52-week high and low, moving averages (50-day and 200-day SMA), relative strength index (RSI), and volume trends. Comparing QIPT's performance against its sector index and the S&P 500 provides context on whether it is outperforming or underperforming the broader market.

What are the risks of investing in QIPT?

Key risk categories for QIPT include: market risk (overall market downturns affecting stock prices), company-specific risk (management changes, product failures, competitive threats), financial risk (high debt levels, cash burn, dilution from stock issuance), regulatory risk (government policy changes, lawsuits, compliance issues), and macroeconomic risk (interest rate changes, inflation, currency fluctuations). Beta measures QIPT's volatility relative to the market - a beta above 1.0 means higher volatility than the S&P 500. Our AI-generated risk assessment identifies the most relevant risk factors for this specific stock.

Are insiders buying or selling QIPT?

Insider trading activity for QIPT tracks purchases and sales by company executives, directors, and major shareholders (10%+ owners) as reported in SEC Form 4 filings. Insider buying is generally considered a bullish signal because insiders have the deepest knowledge of company operations, while selling may have various motivations (diversification, tax planning, pre-planned 10b5-1 trading plans). Key metrics include the buy-to-sell ratio, total dollar value of insider transactions, and whether multiple insiders are trading in the same direction. Our Insider Flow tab shows recent transactions with dates and dollar amounts.

Is QIPT a good stock for beginners?

Quipt Home Medical Corp. (QIPT) can be suitable for beginner investors depending on several factors. Look at the MoonshotScore on this page for an overall AI-powered assessment of growth potential and risk. Beginners should also check the company's market cap (larger companies tend to be less volatile), gross margin (higher margins mean stronger business fundamentals), and cash position (healthy cash reduces bankruptcy risk). Always start with a small position size and never invest money you cannot afford to lose.

How risky is QIPT for first-time investors?

Every stock carries risk, including Quipt Home Medical Corp. (QIPT). First-time investors should review the Risk Factors section on this page for company-specific risks. Key risk indicators include price volatility (check the chart for daily swings), insider selling activity (see Insider Flow tab), and cash runway (see MoonshotScore breakdown). A diversified portfolio with an index fund like the S&P 500 as a core holding is generally recommended before adding individual stocks like QIPT.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Data provided for informational purposes only.

AI Analysis Notes
  • Information is based on available data and may be subject to change.
  • Financial metrics are as of the latest available reporting period.
Data Sources
profilefundamentalsexistingCopy